First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - DALES PHARMA LIMITED

ANALYSIS
Credit Risk Update: ACCOUNTS DUE FLAG: DALES PHARMA LIMITED, 272 Regents Park Road, Finchley Central, London, N3 3HN. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 August 2020. The company was incorporated on 11 February 2004.

The accounts next due date is 31 August 2022. There are no mortgages.

The above was based on public record information as at 1 February 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 05041590
Date Incorporated: 11 February 2004
Date Latest Accounts: 31 August 2020
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: DALES PHARM LIMITED
Registered Number: 05041590
Annual Return: 11 February 2016
Registered Office: 272 Regents Park Road, Finchley Central, London, N3 3HN
SIC Code and Operations: 86900
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

DALES PHARMA LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 11 February 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
00474958 DALES PHARMACEUTICALS LIMITED Active
13564059 DALE'S PHONE BOX LTD Active - Proposal to Strike off
13266150 DALES PLUMBING AND HEATING LTD Active - Proposal to Strike off
10117743 DALES PLUMBING COMPANY LTD Dissolved
11433300 DALES PLUMBING COMPANY LTD Active - Proposal to Strike off

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd